Protara Therapeutics, Inc.

Q2 2022 13F Holders

Symbol
TARA
CUSIP
74365U107
Type
Equity
Class
COM STK
Num filings
34
Total reported value, excl. options
$18.4 M
Manager Report Date Value ($000) Shares Option Type